SCHEMBL4731581

SCHEMBL4731581

COCCN(C(=O)c1ccc(Cl)cc1Cl)c1cc(I)sc1C(=O)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 5/20 0.43
▸ S1PR1 P21453 1/20 0.40
▸ CRHR1 P34998 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.39
▸ KMT2A Q03164 3/20 0.38
▸ FLT1 P17948 1/20 0.38
▸ FLT4 P35916 1/20 0.38
▸ KDR P35968 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ MAPT P10636 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.36
▸ POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4729550 0.90 NPC1 (0.38) CYP3A4S1PR1CRHR1KMT2AMAPT
SCHEMBL4731813 0.84 CYP3A4 (0.45) CYP3A4CRHR1ALDH1A1KMT2AFLT1
SCHEMBL1961753 0.82 CYP3A4 (0.38) CYP3A4S1PR1CRHR1ALDH1A1KMT2A
SCHEMBL4157913 0.80 FLT1 (0.39) CYP3A4ALDH1A1KMT2AFLT1FLT4
SCHEMBL12578110 0.77 CYP3A4 (0.42) CYP3A4S1PR1CRHR1ALDH1A1KMT2A
SCHEMBL4729162 0.75 CCR2 (0.36) CYP3A4ALDH1A1FLT1FLT4KDR
SCHEMBL14223018 0.74 KDM4E (0.37) S1PR1KMT2ASMN1; SMN2MAPTKDM4E
SCHEMBL1961431 0.74 CACNA2D1 (0.41) ALDH1A1CYP1A2CYP2C19KDM4ERAB9A
SCHEMBL1958427 0.73 CYP2E1 (0.41) CYP3A4S1PR1CRHR1ALDH1A1KMT2A
SCHEMBL4730786 0.73 NPC1 (0.36) CYP3A4ALDH1A1FLT1FLT4KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008043791-A2 THIOPHENE DERIVATIVES FOR TREATING HEPATITIS C SMITHKLINE BEECHAM CORPORATION (US) 2008-04-17 — — WO disclosed
WO-2008043791-A2 THIOPHENE DERIVATIVES FOR TREATING HEPATITIS C SMITHKLINE BEECHAM CORPORATION (US) 2008-04-17 — — WO disclosed
Send feedback